HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SYK

Stryker Corporation (S&P 500)

Healthcare — Medical Devices

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Buy 1.7 / 5 25 analysts
$272.96
$-2.43 (-0.88%)
Target: $367.80 (34.7%)

Price History

52-Week Range
Sign in to add SYK to a watchlist or set price alerts.

Fundamentals

Market Cap$104.70B
P/E Ratio (TTM)28.32
Forward P/E16.33
EPS (TTM)$9.64
Dividend Yield1.28%
Profit Margin14.43%
Revenue Growth9.40%
ROE16.51%
Debt/Equity64.39
Recommendation Buy 1.7
Analyst Target$367.80
Analysts25
Next Earnings Oct 29, 2026 AMC
Indexes S&P 500

Technical Indicators

RSI (14)46.9
Beta0.77
SMA 20$278.96
SMA 40$305.79
52-Week High$392.55
52-Week Low$267.00
50-Day Avg$312.81
200-Day Avg$331.01
Avg Volume$2.62M
Volume$2.45M

Performance Analysis

BULLISH

SYK shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($267.00), which could present a value opportunity.
~ RSI at 46.9 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 9.4% year-over-year.
+ Wall Street consensus is "Buy" from 25 analysts.
+ Average analyst target of $367.80 implies 34.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report